Market Forecast by Countries (South Africa, Nigeria, Kenya, Rest of Africa), By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines), By Animal Type (Livestock, Companion), By Route of Administration (Subcutaneous, Intramuscular, Intranasal) And Competitive Landscape
Product Code: ETC391532 | Publication Date: Aug 2022 | Updated Date: Mar 2024 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 250 | No. of Figures: 50 | No. of Tables: 25 | |
Report Name | Africa Animal Vaccines Market |
Forecast period | 2024-2030 |
CAGR | 4.3% |
Growing Sector | Livestock |
Africa Animal Vaccines Market report thoroughly covers the market By Countries, By Product, By Animal Type, and By Route of Administration. The market outlook report provides an unbiased and detailed analysis of the ongoing market trends, opportunities/high growth areas, and market drivers which would help the stakeholders to devise and align their market strategies according to the current and future market dynamics.
Africa Animal Vaccines Market is experiencing a dynamic shift, driven by increasing awareness of animal health and disease prevention across the continent. Factors such as the rising incidence of livestock diseases, growing investments in animal health by governments, and the expanding livestock sector contribute to the Africa Animal Vaccines Market Growth. Additionally, advancements in biotechnological research and vaccine development play a critical role in addressing the specific needs of the African market, including vaccines for diseases unique to the region.
According to 6Wresearch, the Africa Animal Vaccines Market size is anticipated to reach a CAGR of 4.3% during the forecast period of 2024-2030. The growth of the market is driven by several factors, including the increasing prevalence of livestock diseases, rising pet ownership, and growing awareness regarding animal health in the region. Major trends influencing the market include advancements in biotechnological research, the development of novel vaccines, and the adoption of strategic initiatives by key players, such as collaborations and partnerships to expand their geographic reach and product portfolios.
However, the market faces restraints due to the high cost of vaccine storage and transportation, particularly in remote areas, and a lack of infrastructure for effective vaccination campaigns. Despite these challenges, emerging opportunities exist in the expansion of vaccination programs and the introduction of innovative vaccine delivery systems, which are expected to propel the market forward.
In recent years, the government have implemented policies and initiated schemes aimed at bolstering the Africa Animal Vaccines Industry. These initiatives are designed to enhance livestock health, ensuring food security, and supporting the livelihoods of millions dependent on agriculture and animal husbandry. Among these, the Pan-African Vaccine Initiative is noteworthy, aiming to increase access to essential vaccines for livestock across the continent. Additionally, countries like Kenya and Nigeria have introduced subsidies for livestock vaccines, making them more affordable for small-scale farmers. These government actions represent a significant commitment to agricultural sustainability and public health in Africa. The Pan-African Vaccine Initiative (PAVI) was launched in 2004 by the African Union's Inter-African Bureau for Animal Resources (AU-IBAR) and the International Livestock Research Institute (ILRI). Its goal is to strengthen the capacity of national veterinary services in Africa to produce, distribute, and regulate quality vaccines.
The market is characterized by the presence of global pharmaceutical giants as well as emerging local companies that specialize in animal health. Major players, such as Zoetis, Merck Animal Health, and Elanco, have established a strong foothold through strategic partnerships with local government bodies and private sector initiatives.
The Africa Animal Vaccines Market is poised for growth, driven by increasing awareness about the benefits of livestock vaccination and government efforts to enhance animal health infrastructure. Technological advancements in vaccine storage and delivery, alongside growing investments in R&D, are expected to propel the development of more effective and longer-lasting vaccine solutions. Consequently, this growth is anticipated to not only improve animal health and productivity but also contribute to food security and economic stability across the continent. Additionally, the integration of digital technologies such as blockchain and artificial intelligence in animal health management is also likely to create new opportunities for market players.
According to Shubham, Senior Research Analyst, 6Wresearch, the DNA vaccines is projected to dominate the Africa Animal Vaccines Market Share mainly due to their ability to induce a strong and specific immune response with fewer side effects, their stability at room temperature, which simplifies storage and transportation requirements, and the flexibility in their design.
By Route of Administration, the subcutaneous segment is currently witnessing the robust growth owing to the ease of administration, reduced stress for the animals, and the effectiveness of the immune response generated by vaccines delivered subcutaneously.
The report offers a comprehensive study of the subsequent market segments:
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Africa Animal Vaccines Market Overview |
3.1 Africa Regional Macro Economic Indicators |
3.2 Africa Animal Vaccines Market Revenues & Volume, 2020 & 2030F |
3.3 Africa Animal Vaccines Market - Industry Life Cycle |
3.4 Africa Animal Vaccines Market - Porter's Five Forces |
3.5 Africa Animal Vaccines Market Revenues & Volume Share, By Countries, 2020 & 2030F |
3.6 Africa Animal Vaccines Market Revenues & Volume Share, By Product, 2020 & 2030F |
3.7 Africa Animal Vaccines Market Revenues & Volume Share, By Animal Type, 2020 & 2030F |
3.8 Africa Animal Vaccines Market Revenues & Volume Share, By Route of Administration, 2020 & 2030F |
4 Africa Animal Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Africa Animal Vaccines Market Trends |
6 Africa Animal Vaccines Market, 2020 - 2030 |
6.1 Africa Animal Vaccines Market, Revenues & Volume, By Product, 2020 - 2030 |
6.2 Africa Animal Vaccines Market, Revenues & Volume, By Animal Type, 2020 - 2030 |
6.3 Africa Animal Vaccines Market, Revenues & Volume, By Route of Administration, 2020 - 2030 |
7 South Africa Animal Vaccines Market, 2020 - 2030 |
7.1 South Africa Animal Vaccines Market, Revenues & Volume, By Product, 2020 - 2030 |
7.2 South Africa Animal Vaccines Market, Revenues & Volume, By Animal Type, 2020 - 2030 |
7.3 South Africa Animal Vaccines Market, Revenues & Volume, By Route of Administration, 2020 - 2030 |
8 Nigeria Animal Vaccines Market, 2020 - 2030 |
8.1 Nigeria Animal Vaccines Market, Revenues & Volume, By Product, 2020 - 2030 |
8.2 Nigeria Animal Vaccines Market, Revenues & Volume, By Animal Type, 2020 - 2030 |
8.3 Nigeria Animal Vaccines Market, Revenues & Volume, By Route of Administration, 2020 - 2030 |
9 Kenya Animal Vaccines Market, 2020 - 2030 |
9.1 Kenya Animal Vaccines Market, Revenues & Volume, By Product, 2020 - 2030 |
9.2 Kenya Animal Vaccines Market, Revenues & Volume, By Animal Type, 2020 - 2030 |
9.3 Kenya Animal Vaccines Market, Revenues & Volume, By Route of Administration, 2020 - 2030 |
10 Rest of Africa Animal Vaccines Market, 2020 - 2030 |
10.1 Rest of Africa Animal Vaccines Market, Revenues & Volume, By Product, 2020 - 2030 |
10.2 Rest of Africa Animal Vaccines Market, Revenues & Volume, By Animal Type, 2020 - 2030 |
10.3 Rest of Africa Animal Vaccines Market, Revenues & Volume, By Route of Administration, 2020 - 2030 |
11 Africa Animal Vaccines Market Key Performance Indicators |
12 Africa Animal Vaccines Market - Opportunity Assessment |
12.1 Africa Animal Vaccines Market Opportunity Assessment, By Countries, 2020 & 2030F |
12.2 Africa Animal Vaccines Market Opportunity Assessment, By Product, 2020 & 2030F |
12.3 Africa Animal Vaccines Market Opportunity Assessment, By Animal Type, 2020 & 2030F |
12.4 Africa Animal Vaccines Market Opportunity Assessment, By Route of Administration, 2020 & 2030F |
13 Africa Animal Vaccines Market - Competitive Landscape |
13.1 Africa Animal Vaccines Market Revenue Share, By Companies, 2023 |
13.2 Africa Animal Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
14 Company Profiles |
15 Recommendations |
16 Disclaimer |